{"id":599,"date":"2016-04-05T10:42:49","date_gmt":"2016-04-05T08:42:49","guid":{"rendered":"http:\/\/www.nanexa.com\/nanexa-lamnar-in-tva-nya-patentansokningar\/"},"modified":"2017-05-03T00:00:18","modified_gmt":"2017-05-02T22:00:18","slug":"nanexa-lamnar-in-tva-nya-patentansokningar","status":"publish","type":"post","link":"https:\/\/nanexa.com\/sv\/nanexa-lamnar-in-tva-nya-patentansokningar\/","title":{"rendered":"Nanexa: L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar"},"content":{"rendered":"<p style=\"font-family: arial,helvetica,sans-serif;\"><span style=\"font-size: 10pt;\">Det senaste \u00e5rets arbete med PharmaShell\u00ae har lett till flera tekniska framsteg, inom befintliga men ocks\u00e5 inom nya produktomr\u00e5den och d\u00e4rf\u00f6r har Nanexa beslutat att l\u00e4mna in tv\u00e5 nya patentans\u00f6kningar.<\/span><\/p>\n<p style=\"font-family: arial,helvetica,sans-serif;\"><span style=\"font-size: 10pt;\">Patentans\u00f6kningarna avser nya produkter, metoder och anv\u00e4ndningsomr\u00e5den inom ramen f\u00f6r drug delivery-systemet PharmaShell\u00ae och de l\u00e4mnades in vid det Europeiska patentverket (EPO) den 5 april 2016. Inom prioritets\u00e5ret finns m\u00f6jlighet att f\u00f6lja upp de europeiska patentans\u00f6kningarna med internationella patentans\u00f6kningar (PCT-ans\u00f6kningar) vilket Nanexa \u00e4mnar g\u00f6ra.<\/span><\/p>\n<p style=\"font-family: arial,helvetica,sans-serif;\"><span style=\"font-size: 10pt;\">Nanexas VD David Westberg s\u00e4ger att immateriella r\u00e4ttigheter i allm\u00e4nhet och patent i synnerhet \u00e4r v\u00e4ldigt viktigt f\u00f6r Nanexas verksamhet. \u201dGenom de h\u00e4r tv\u00e5 nya patentans\u00f6kningarna f\u00f6rst\u00e4rker vi skyddet kring PharmaShell\u00ae och dessutom ger de oss m\u00f6jlighet att komma in p\u00e5 helt nya aff\u00e4rsomr\u00e5den med v\u00e5rt drug delivery-system.\u201d<\/span><\/p>\n<p style=\"font-family: arial,helvetica,sans-serif;\"><span style=\"font-size: 10pt;\">F\u00f6r mer information kontakta:<\/span><\/p>\n<p style=\"font-family: arial,helvetica,sans-serif;\"><span style=\"font-size: 10pt;\">David Westberg \u2013 VD, Nanexa AB (publ)\u00a0<\/span><\/p>\n<p style=\"font-family: arial,helvetica,sans-serif;\"><span style=\"font-size: 10pt;\">\u2028Telefon: 0709 -42 83 03\u2028<\/span><\/p>\n<p style=\"font-family: arial,helvetica,sans-serif;\"><span style=\"font-size: 10pt;\">E-post:\u00a0<a href=\"mailto:david.westberg@nanexa.se\">david.westberg@nanexa.se<\/a><\/span><\/p>\n<p style=\"font-family: arial,helvetica,sans-serif;\"><span style=\"font-size: 10pt;\"><a href=\"http:\/\/www.nanexa.se\/\">www.nanexa.se<\/a><\/span><\/p>\n<p style=\"font-family: arial,helvetica,sans-serif;\"><span style=\"font-size: 10pt;\">Om Nanexa AB (publ)<\/span><\/p>\n<p style=\"font-family: arial,helvetica,sans-serif;\"><span style=\"font-size: 10pt;\">Nanexa AB \u00e4r ett h\u00f6gteknologiskt forskningsf\u00f6retag som utvecklar och marknadsf\u00f6r produkter inom nanoteknologi. Bolagets fokus ligger p\u00e5 PharmaShell\u00ae som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal omr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae har Nanexa samarbetsavtal med bland andra AstraZeneca och Uppsala universitet.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p style=\"font-family: arial,helvetica,sans-serif;\">Det senaste \u00e5rets arbete med PharmaShell\u00ae har lett till flera tekniska framsteg, inom befintliga men ocks\u00e5 inom nya produktomr\u00e5den och d\u00e4rf\u00f6r har Nanexa beslutat att l\u00e4mna in tv\u00e5 nya patentans\u00f6kningar.<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/nanexa.com\/sv\/nanexa-lamnar-in-tva-nya-patentansokningar\/\">L\u00e4s mer<\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[7],"tags":[],"class_list":["post-599","post","type-post","status-publish","format-standard","hentry","category-nyheter"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanexa: L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/nanexa-lamnar-in-tva-nya-patentansokningar\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa: L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Det senaste \u00e5rets arbete med PharmaShell\u00ae har lett till flera tekniska framsteg, inom befintliga men ocks\u00e5 inom nya produktomr\u00e5den och d\u00e4rf\u00f6r har Nanexa beslutat att l\u00e4mna in tv\u00e5 nya patentans\u00f6kningar.L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/nanexa-lamnar-in-tva-nya-patentansokningar\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:published_time\" content=\"2016-04-05T08:42:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-05-02T22:00:18+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-lamnar-in-tva-nya-patentansokningar\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-lamnar-in-tva-nya-patentansokningar\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Nanexa: L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar\",\"datePublished\":\"2016-04-05T08:42:49+00:00\",\"dateModified\":\"2017-05-02T22:00:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-lamnar-in-tva-nya-patentansokningar\\\/\"},\"wordCount\":239,\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"articleSection\":[\"Nyheter\"],\"inLanguage\":\"sv-SE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-lamnar-in-tva-nya-patentansokningar\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/nanexa-lamnar-in-tva-nya-patentansokningar\\\/\",\"name\":\"Nanexa: L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2016-04-05T08:42:49+00:00\",\"dateModified\":\"2017-05-02T22:00:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-lamnar-in-tva-nya-patentansokningar\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/nanexa-lamnar-in-tva-nya-patentansokningar\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-lamnar-in-tva-nya-patentansokningar\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanexa: L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa: L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/nanexa-lamnar-in-tva-nya-patentansokningar\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa: L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar - Nanexa AB","og_description":"Det senaste \u00e5rets arbete med PharmaShell\u00ae har lett till flera tekniska framsteg, inom befintliga men ocks\u00e5 inom nya produktomr\u00e5den och d\u00e4rf\u00f6r har Nanexa beslutat att l\u00e4mna in tv\u00e5 nya patentans\u00f6kningar.L\u00e4s mer","og_url":"https:\/\/nanexa.com\/nanexa-lamnar-in-tva-nya-patentansokningar\/","og_site_name":"Nanexa AB","article_published_time":"2016-04-05T08:42:49+00:00","article_modified_time":"2017-05-02T22:00:18+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanexa.com\/nanexa-lamnar-in-tva-nya-patentansokningar\/#article","isPartOf":{"@id":"https:\/\/nanexa.com\/nanexa-lamnar-in-tva-nya-patentansokningar\/"},"author":{"name":"","@id":""},"headline":"Nanexa: L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar","datePublished":"2016-04-05T08:42:49+00:00","dateModified":"2017-05-02T22:00:18+00:00","mainEntityOfPage":{"@id":"https:\/\/nanexa.com\/nanexa-lamnar-in-tva-nya-patentansokningar\/"},"wordCount":239,"publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"articleSection":["Nyheter"],"inLanguage":"sv-SE"},{"@type":"WebPage","@id":"https:\/\/nanexa.com\/nanexa-lamnar-in-tva-nya-patentansokningar\/","url":"https:\/\/nanexa.com\/nanexa-lamnar-in-tva-nya-patentansokningar\/","name":"Nanexa: L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2016-04-05T08:42:49+00:00","dateModified":"2017-05-02T22:00:18+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/nanexa-lamnar-in-tva-nya-patentansokningar\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/nanexa-lamnar-in-tva-nya-patentansokningar\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/nanexa-lamnar-in-tva-nya-patentansokningar\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"Nanexa: L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/599","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/comments?post=599"}],"version-history":[{"count":1,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/599\/revisions"}],"predecessor-version":[{"id":602,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/599\/revisions\/602"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=599"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/categories?post=599"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/tags?post=599"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}